Princeton Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.44M Sell
14,475
-561
-4% -$250K 1.91% 11
2025
Q1
$7.29M Sell
15,036
-138
-0.9% -$66.9K 2.57% 8
2024
Q4
$6.11M Buy
15,174
+64
+0.4% +$25.8K 1.89% 11
2024
Q3
$7.03M Buy
15,110
+74
+0.5% +$34.4K 2.21% 11
2024
Q2
$7.05M Sell
15,036
-193
-1% -$90.5K 2.3% 9
2024
Q1
$6.37M Sell
15,229
-66
-0.4% -$27.6K 2.3% 9
2023
Q4
$6.22M Sell
15,295
-73
-0.5% -$29.7K 2.51% 10
2023
Q3
$5.34M Sell
15,368
-205
-1% -$71.3K 2.46% 9
2023
Q2
$5.48M Buy
15,573
+198
+1% +$69.7K 2.28% 8
2023
Q1
$4.84M Sell
15,375
-720
-4% -$227K 2.07% 13
2022
Q4
$4.65M Sell
16,095
-164
-1% -$47.4K 2.07% 14
2022
Q3
$4.71M Buy
16,259
+297
+2% +$86K 2.06% 14
2022
Q2
$4.5M Sell
15,962
-451
-3% -$127K 1.74% 15
2022
Q1
$4.28M Sell
16,413
-168
-1% -$43.8K 1.33% 20
2021
Q4
$3.64M Sell
16,581
-510
-3% -$112K 1.04% 29
2021
Q3
$3.1M Buy
17,091
+156
+0.9% +$28.3K 0.99% 33
2021
Q2
$3.42M Buy
16,935
+223
+1% +$45K 1.06% 30
2021
Q1
$3.59M Buy
16,712
+322
+2% +$69.2K 1.21% 28
2020
Q4
$3.87M Sell
16,390
-656
-4% -$155K 1.39% 23
2020
Q3
$4.64M Buy
17,046
+195
+1% +$53.1K 1.87% 17
2020
Q2
$4.89M Buy
16,851
+1,296
+8% +$376K 2.17% 14
2020
Q1
$4.2M Sell
15,555
-2,238
-13% -$604K 2.18% 15
2019
Q4
$4.27M Sell
17,793
-97
-0.5% -$23.3K 1.91% 17
2019
Q3
$3.03M Buy
17,890
+106
+0.6% +$18K 1.47% 23
2019
Q2
$3.26M Buy
17,784
+359
+2% +$65.8K 1.59% 21
2019
Q1
$3.21M Sell
17,425
-605
-3% -$111K 1.62% 22
2018
Q4
$2.99M Sell
18,030
-1,009
-5% -$167K 1.74% 21
2018
Q3
$3.67M Sell
19,039
-350
-2% -$67.5K 1.52% 25
2018
Q2
$3.3M Sell
19,389
-166
-0.8% -$28.2K 1.43% 25
2018
Q1
$3.19M Sell
19,555
-831
-4% -$135K 1.42% 25
2017
Q4
$3.06M Buy
+20,386
New +$3.06M 1.37% 26